#CirculatingTumorCells
LightNews LightNews
screencell.bsky.social
📍 ScreenCell at SU2C Scientific Summit 2026!

Our CTO Sina NASERIAN, Ph.D. will present : "Transforming Cancer Monitoring: The Impact of #CirculatingTumorCells"

🗓️ Jan 31 | 2:45-3:00 PM PST
📍 Session 4: Minimally Invasive Measurements

#LiquidBiopsy

@su2c.bsky.social
@screencell.bsky.social
January 27, 2026 at 1:59 PM
screencell.bsky.social
🔬 Discover every detail of our isolation platform for capturing #circulatingtumorcells using #liquidbiopsy 🩸

Would you like to know how to integrate our technology into your #research project?

Contact us : lnkd.in/edURqtjQ
July 16, 2025 at 8:48 AM
alicefrolov.bsky.social
Figure title: "Epithelial-to-mesenchymal marker plasticity across the metastatic cascade"

Subtitle: "Single-cell E-cadherin vs Vimentin coordinates reveal hybrid E/M states enriched at invasion and CTC stages"

#EMT #TumorMetastasis #CancerCellPlasticity #CirculatingTumorCells #SingleCellAnalysis
Figure title: "Epithelial-to-mesenchymal marker plasticity across the metastatic cascade" Subtitle: "Single-cell E-cadherin vs Vimentin coordinates reveal hybrid E/M states enriched at invasion and CTC stages" The visualization is a hexbin-style 2D marker landscape in which each cell is positioned by its E-cadherin (x-axis) and Vimentin (y-axis) expression coordinates, with hexagonal binning encoding local cell density. The panel is faceted by cascade stage — primary tumor, local invasion, intravasation/CTC, and metastatic colonization — and each facet carries marginal density strips summarizing the univariate distribution of each marker. In the primary tumor facet, density concentrates in the E-cadherin-high/Vimentin-low quadrant, consistent with a predominantly epithelial phenotype. At the invasion and CTC stages, the landscape shifts toward the diagonal, with substantial occupancy of the intermediate quadrant where both markers are co-expressed. This bivariate co-occupancy operationalizes the hybrid E/M state, reflecting partial-EMT programs rather than a binary epithelial-to-mesenchymal switch. The colonization facet shows partial reversion toward the epithelial pole, congruent with mesenchymal-to-epithelial transition (MET) supporting secondary outgrowth. I want to emphasize that the underlying data are simulated. The intent is to illustrate a literature-grounded trend — the enrichment of hybrid E/M phenotypes at dissemination-competent stages, associated with collective migration, enhanced tumor-initiating capacity, and CTC cluster formation — rather than to report empirical measurements. Marker coordinates were sampled to reproduce reported qualitative shifts along the cascade. I would welcome critique on the choice of E-cadherin/Vimentin as the state axes versus incorporating additional determinants (ZEB1, SNAI1, GRHL2, OVOL2) or a continuous EMT-scoring metric.
September 2, 2026 at 5:00 PM
theinnovation.bsky.social
This review adopts the CTC single-cell omics analysis workflow as an organizing framework and systematically examine the major CTC enrichment strategies and their inherent limitations.
doi.org/10.59717/j.x...
#Singlecellomics #Circulatingtumorcells
August 25, 2026 at 3:02 AM
cancers-mdpi.bsky.social
📖#LiquidBiopsies in the Early Diagnosis, Prognosis, and Tailored Treatment of #ColorectalCancer
🧑‍⚕️Authors: Efstathia Liatsou, Ioannis Kollias et al.
Citations: 11🎉
Unlock🔓 www.mdpi.com/2072-6694/17...
#diagnosis #prognosis #treatment #circulatingtumorcells
Figure 1. Circulating biomarkers in colorectal cancer. Circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), extracellular vesicles (EVs), and non-coding RNA (ncRNA) are the main liquid biopsy representatives that are shed from the primary tumor and the metastatic sites into the bloodstream. CTCs are introduced into the circulation by intravasation and contain ctDNA and ncRNA. Both ctDNA and ncRNA can also be shed into the circulation via EV secretion from the tumor or by cell-death processes like apoptosis and necrosis. Similarly, EVs can either be actively shed into the bloodstream, serving as signaling-molecule carriers, or be products of apoptosis.
August 13, 2026 at 5:34 AM
medcomm.bsky.social
#Letter in @MedComm_MC
Size Matters: Small Circulating Tumor Cells Indicate Worse Therapy Response in Breast Cancer doi.org/10.1002/mco2...

#CellMorphology #CirculatingTumorCells #FlowCytometry #TherapyResponse
November 14, 2025 at 3:45 AM
screencell.bsky.social
📢 ScreenCell® kits evolving in 2026

Starting Jan 1st: standardized format across our 7 #CTC isolation kits :

✅ 2 filtration units + 1 buffer

Affecting CYTO, CSB, MB & MBSB kits.

Full details 👉 www.screencell.com/en/news/prod...

#liquidbiopsy #screencell #circulatingtumorcells
On the left, 2 CYTO filtration units with FC2 dilution buffer, and on the right, 2 MB filtration units with LC dilution buffer.
November 19, 2025 at 10:23 AM
screencell.bsky.social
What if you could isolate #circulatingtumorcells (#CTCs) faster than reading a scientific publication? 📖

With our single-use isolation devices, isolate your CTCs using #liquidbiopsy in less than 10 minutes, with a recovery rate greater than 90%. ⚡
September 16, 2025 at 9:06 AM
screencell.bsky.social
For over 10 years, at , we’ve chosen to offer the scientific community a liquidbiopsy technology for isolating #circulatingtumorcells (#CTCs) that is both high-performing and economically accessible.
July 29, 2025 at 9:06 AM
bionewscentral.com
Doctors may be able to spare patients unnecessarily aggressive #BreastCancerTreatments by collecting and testing #CancerCells in patients' #blood.
#BreastCancer #CirculatingTumorCells #PredictiveBiomarkers
Capturing cancer cells from blood could help doctors choose the right breast cancer treatment – BioNews Central
Doctors may be able to spare patients unnecessarily aggressive breast cancer treatments by collecting and testing cancer cells in patients' blood. ...
sbee.link
October 30, 2025 at 12:39 PM
arxivlens.bsky.social
DTCFinder: a bench-to-bits toolkit for label-free, whole-spectrum analysis of disseminated and circulating tumor cells in liquid biopsies
Li, Z. et al.
Paper
Details
#LiquidBiopsy #CirculatingTumorCells #DTCFinder
December 19, 2025 at 9:03 AM